DNA content and cell kinetics in colorectal carcinoma: Flow cytometric analysis of primary tumor and liver metastases

M. Danova, M. R. De Renzis, M. Girino, L. Valenti, O. Mora, M. Scabini, G. Mazzini, A. Riccardi

Research output: Contribution to journalArticle

Abstract

Aims and background: Both flow cytometric DNA ploidy and proliferative activity have been indicated as potential prognostic indicators in colorectal cancer. Due to tumor biological heterogeneity, these parameters are best assessed with multiple sampling. Methods: We undertook a prospective study on 52 patients with Duke's D colorectal tumors looking at multiple samples of the primary tumors and liver metastases. DNA ploidy and tumor proliferative activity (derived from proliferating cell nuclear antigen, PCNA FCM expression) were evaluated. Results: Of primary tumors, 36/52 (69,2%) were aneuploid in at least 1 sample, with a median value of the DNA index of the aneuploid peak of 1.58. On liver metastases, 42/52 (80,7%) patients were aneuploid in at least 1 sample with a median DNA index of the aneuploid peak of 1.64. Identical or nearly identical histograms from different tumor samples were observed in only 18/52 (34.6%) of the primary tumors and in 15/52 (28.8%) of the liver metastases. The PCNA values for primary tumors ranged from 5 to 28% (median value = 16.5%). In the liver metastases, PCNA values ranged from 12 to 38% (median value = 19.8%). Proliferative activity was lower for diploid than for aneuploid tumors. DNA ploidy and PCNA expression of the deep specimen of primary tumors were similar to those of the liver metastasis of the same patient while this concordance was not complete in the case of superficial biopsy specimens. Conclusions: If correctly performed, FCM techniques allow an accurate analysis of DNA ploidy and proliferative activity and both these measurements can offer considerable potential for a more comprehensive approach to colorectal cancer.

Original languageEnglish
Pages (from-to)12-15
Number of pages4
JournalTumori
Volume81
Issue number3 SUPPL.
Publication statusPublished - 1995

Fingerprint

Colorectal Neoplasms
Neoplasm Metastasis
Proliferating Cell Nuclear Antigen
Aneuploidy
Liver
DNA
Ploidies
Neoplasms
Diploidy
Prospective Studies
Biopsy

Keywords

  • colorectal cancer
  • DNA ploidy
  • flow cytometry
  • prognosis
  • proliferative activity

ASJC Scopus subject areas

  • Cancer Research

Cite this

Danova, M., De Renzis, M. R., Girino, M., Valenti, L., Mora, O., Scabini, M., ... Riccardi, A. (1995). DNA content and cell kinetics in colorectal carcinoma: Flow cytometric analysis of primary tumor and liver metastases. Tumori, 81(3 SUPPL.), 12-15.

DNA content and cell kinetics in colorectal carcinoma : Flow cytometric analysis of primary tumor and liver metastases. / Danova, M.; De Renzis, M. R.; Girino, M.; Valenti, L.; Mora, O.; Scabini, M.; Mazzini, G.; Riccardi, A.

In: Tumori, Vol. 81, No. 3 SUPPL., 1995, p. 12-15.

Research output: Contribution to journalArticle

Danova, M, De Renzis, MR, Girino, M, Valenti, L, Mora, O, Scabini, M, Mazzini, G & Riccardi, A 1995, 'DNA content and cell kinetics in colorectal carcinoma: Flow cytometric analysis of primary tumor and liver metastases', Tumori, vol. 81, no. 3 SUPPL., pp. 12-15.
Danova M, De Renzis MR, Girino M, Valenti L, Mora O, Scabini M et al. DNA content and cell kinetics in colorectal carcinoma: Flow cytometric analysis of primary tumor and liver metastases. Tumori. 1995;81(3 SUPPL.):12-15.
Danova, M. ; De Renzis, M. R. ; Girino, M. ; Valenti, L. ; Mora, O. ; Scabini, M. ; Mazzini, G. ; Riccardi, A. / DNA content and cell kinetics in colorectal carcinoma : Flow cytometric analysis of primary tumor and liver metastases. In: Tumori. 1995 ; Vol. 81, No. 3 SUPPL. pp. 12-15.
@article{148ce73aa930457e96a6e685e0a0d476,
title = "DNA content and cell kinetics in colorectal carcinoma: Flow cytometric analysis of primary tumor and liver metastases",
abstract = "Aims and background: Both flow cytometric DNA ploidy and proliferative activity have been indicated as potential prognostic indicators in colorectal cancer. Due to tumor biological heterogeneity, these parameters are best assessed with multiple sampling. Methods: We undertook a prospective study on 52 patients with Duke's D colorectal tumors looking at multiple samples of the primary tumors and liver metastases. DNA ploidy and tumor proliferative activity (derived from proliferating cell nuclear antigen, PCNA FCM expression) were evaluated. Results: Of primary tumors, 36/52 (69,2{\%}) were aneuploid in at least 1 sample, with a median value of the DNA index of the aneuploid peak of 1.58. On liver metastases, 42/52 (80,7{\%}) patients were aneuploid in at least 1 sample with a median DNA index of the aneuploid peak of 1.64. Identical or nearly identical histograms from different tumor samples were observed in only 18/52 (34.6{\%}) of the primary tumors and in 15/52 (28.8{\%}) of the liver metastases. The PCNA values for primary tumors ranged from 5 to 28{\%} (median value = 16.5{\%}). In the liver metastases, PCNA values ranged from 12 to 38{\%} (median value = 19.8{\%}). Proliferative activity was lower for diploid than for aneuploid tumors. DNA ploidy and PCNA expression of the deep specimen of primary tumors were similar to those of the liver metastasis of the same patient while this concordance was not complete in the case of superficial biopsy specimens. Conclusions: If correctly performed, FCM techniques allow an accurate analysis of DNA ploidy and proliferative activity and both these measurements can offer considerable potential for a more comprehensive approach to colorectal cancer.",
keywords = "colorectal cancer, DNA ploidy, flow cytometry, prognosis, proliferative activity",
author = "M. Danova and {De Renzis}, {M. R.} and M. Girino and L. Valenti and O. Mora and M. Scabini and G. Mazzini and A. Riccardi",
year = "1995",
language = "English",
volume = "81",
pages = "12--15",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "3 SUPPL.",

}

TY - JOUR

T1 - DNA content and cell kinetics in colorectal carcinoma

T2 - Flow cytometric analysis of primary tumor and liver metastases

AU - Danova, M.

AU - De Renzis, M. R.

AU - Girino, M.

AU - Valenti, L.

AU - Mora, O.

AU - Scabini, M.

AU - Mazzini, G.

AU - Riccardi, A.

PY - 1995

Y1 - 1995

N2 - Aims and background: Both flow cytometric DNA ploidy and proliferative activity have been indicated as potential prognostic indicators in colorectal cancer. Due to tumor biological heterogeneity, these parameters are best assessed with multiple sampling. Methods: We undertook a prospective study on 52 patients with Duke's D colorectal tumors looking at multiple samples of the primary tumors and liver metastases. DNA ploidy and tumor proliferative activity (derived from proliferating cell nuclear antigen, PCNA FCM expression) were evaluated. Results: Of primary tumors, 36/52 (69,2%) were aneuploid in at least 1 sample, with a median value of the DNA index of the aneuploid peak of 1.58. On liver metastases, 42/52 (80,7%) patients were aneuploid in at least 1 sample with a median DNA index of the aneuploid peak of 1.64. Identical or nearly identical histograms from different tumor samples were observed in only 18/52 (34.6%) of the primary tumors and in 15/52 (28.8%) of the liver metastases. The PCNA values for primary tumors ranged from 5 to 28% (median value = 16.5%). In the liver metastases, PCNA values ranged from 12 to 38% (median value = 19.8%). Proliferative activity was lower for diploid than for aneuploid tumors. DNA ploidy and PCNA expression of the deep specimen of primary tumors were similar to those of the liver metastasis of the same patient while this concordance was not complete in the case of superficial biopsy specimens. Conclusions: If correctly performed, FCM techniques allow an accurate analysis of DNA ploidy and proliferative activity and both these measurements can offer considerable potential for a more comprehensive approach to colorectal cancer.

AB - Aims and background: Both flow cytometric DNA ploidy and proliferative activity have been indicated as potential prognostic indicators in colorectal cancer. Due to tumor biological heterogeneity, these parameters are best assessed with multiple sampling. Methods: We undertook a prospective study on 52 patients with Duke's D colorectal tumors looking at multiple samples of the primary tumors and liver metastases. DNA ploidy and tumor proliferative activity (derived from proliferating cell nuclear antigen, PCNA FCM expression) were evaluated. Results: Of primary tumors, 36/52 (69,2%) were aneuploid in at least 1 sample, with a median value of the DNA index of the aneuploid peak of 1.58. On liver metastases, 42/52 (80,7%) patients were aneuploid in at least 1 sample with a median DNA index of the aneuploid peak of 1.64. Identical or nearly identical histograms from different tumor samples were observed in only 18/52 (34.6%) of the primary tumors and in 15/52 (28.8%) of the liver metastases. The PCNA values for primary tumors ranged from 5 to 28% (median value = 16.5%). In the liver metastases, PCNA values ranged from 12 to 38% (median value = 19.8%). Proliferative activity was lower for diploid than for aneuploid tumors. DNA ploidy and PCNA expression of the deep specimen of primary tumors were similar to those of the liver metastasis of the same patient while this concordance was not complete in the case of superficial biopsy specimens. Conclusions: If correctly performed, FCM techniques allow an accurate analysis of DNA ploidy and proliferative activity and both these measurements can offer considerable potential for a more comprehensive approach to colorectal cancer.

KW - colorectal cancer

KW - DNA ploidy

KW - flow cytometry

KW - prognosis

KW - proliferative activity

UR - http://www.scopus.com/inward/record.url?scp=0029121540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029121540&partnerID=8YFLogxK

M3 - Article

C2 - 7571041

AN - SCOPUS:0029121540

VL - 81

SP - 12

EP - 15

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 3 SUPPL.

ER -